Publication | Closed Access

Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia

Metabolic SyndromeLipid DisorderOxysterolBiochemistryCardiovascular DiseaseAdenosine Triphosphate-citrate LyaseMedicineHyperlipidemiaVascular BiologyPharmacologyNovel Dual ModulatorAtherosclerosisDyslipidemia